Key result
LDL aggregation in a model reproducing circulation flow was 200-fold slower and was substantially inhibited by plasma components, particularly albumin.
Plasma components, particularly albumin, and the characteristics of blood flow prevent LDL aggregation within the circulation.
Answers are grounded in this paper and cite their sources.
Indicates LDL aggregation unlikely in circulating blood; leaves open its role in human plaque formation.
LDL aggregates when exposed to even moderate fluid mechanical stresses in the laboratory, yet its half-life in the circulation is 2-3 days, implying that little aggregation occurs. LDL may be protected from aggregation in vivo by components of plasma, or by a qualitative difference in flows. Previous studies have shown that HDL and albumin inhibit the aggregation induced by vortexing. Using a more reproducible method of inducing aggregation and assessing aggregation both spectrophotometrically and by sedimentation techniques, we showed that at physiological concentrations, albumin is the more effective inhibitor, and that aggregation is substantially but not completely inhibited in plasma. Heat denatured and fatty-acid-stripped albumin were more effective inhibitors than normal albumin, supporting the idea that hydrophobic interactions are involved. Aggregation of LDL in a model reproducing several aspects of flow in the circulation was 200-fold slower, but was still inhibited by HDL and albumin, suggesting similar mechanisms are involved. Within the sensitivity of our technique, LDL aggregation did not occur in plasma exposed to these flows. Thus, as a result of the characteristics of blood flow and the inhibitory effects of plasma components, particularly albumin, LDL aggregation is unlikely to occur within the circulation.
No takes yet. Share an insight, caveat, or question.
Talbot et al. (2003) studied LDL aggregation. Fluid mechanical stresses and plasma constituents was evaluated on LDL aggregation. LDL aggregation in a model reproducing circulation flow was 200-fold slower and was substantially inhibited by plasma components, particularly albumin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: